Cubist Pharmaceuticals, Inc. (CBST) Reports Q1 EPS of $0.10

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q1 EPS of $0.10, versus $0.34 reported last year. Revenue for the quarter came in at $261.2 million versus the consensus estimate of $285.24 million.

For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.

You May Also Be Interested In

• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance
• X Financial (XYF) Tops Q2 EPS by 438c
• DA Davidson Reiterates Buy Rating on Wabash National (WNC)